CAMICI, PAOLO
 Distribuzione geografica
Continente #
AS - Asia 7.277
EU - Europa 6.364
NA - Nord America 3.790
SA - Sud America 1.835
AF - Africa 143
Continente sconosciuto - Info sul continente non disponibili 13
OC - Oceania 8
Totale 19.430
Nazione #
RU - Federazione Russa 4.003
US - Stati Uniti d'America 3.644
SG - Singapore 2.593
CN - Cina 2.510
BR - Brasile 1.535
SE - Svezia 1.015
HK - Hong Kong 994
VN - Vietnam 656
FR - Francia 373
IT - Italia 255
DE - Germania 203
IN - India 128
AR - Argentina 119
GB - Regno Unito 101
FI - Finlandia 96
BD - Bangladesh 75
AT - Austria 68
MX - Messico 63
IE - Irlanda 60
ID - Indonesia 57
EC - Ecuador 53
CA - Canada 51
ZA - Sudafrica 51
UA - Ucraina 49
IQ - Iraq 41
CO - Colombia 35
PK - Pakistan 33
PL - Polonia 32
TR - Turchia 30
ES - Italia 29
MA - Marocco 25
PY - Paraguay 25
VE - Venezuela 25
UZ - Uzbekistan 23
CL - Cile 22
NL - Olanda 21
SA - Arabia Saudita 21
KE - Kenya 18
TN - Tunisia 18
JP - Giappone 16
PE - Perù 12
EG - Egitto 11
AE - Emirati Arabi Uniti 10
LT - Lituania 10
MY - Malesia 10
DO - Repubblica Dominicana 8
IL - Israele 8
AL - Albania 7
AU - Australia 7
AZ - Azerbaigian 7
JO - Giordania 7
KZ - Kazakistan 7
LB - Libano 7
NP - Nepal 7
BH - Bahrain 6
DK - Danimarca 6
DZ - Algeria 6
A2 - ???statistics.table.value.countryCode.A2??? 5
BY - Bielorussia 5
PH - Filippine 5
UY - Uruguay 5
BG - Bulgaria 4
CR - Costa Rica 4
ET - Etiopia 4
HN - Honduras 4
JM - Giamaica 4
OM - Oman 4
TT - Trinidad e Tobago 4
XK - ???statistics.table.value.countryCode.XK??? 4
BA - Bosnia-Erzegovina 3
BE - Belgio 3
BO - Bolivia 3
CH - Svizzera 3
CZ - Repubblica Ceca 3
EU - Europa 3
KR - Corea 3
KW - Kuwait 3
AM - Armenia 2
AO - Angola 2
GA - Gabon 2
GE - Georgia 2
HR - Croazia 2
IR - Iran 2
LV - Lettonia 2
MD - Moldavia 2
NO - Norvegia 2
PS - Palestinian Territory 2
PT - Portogallo 2
QA - Qatar 2
RO - Romania 2
TG - Togo 2
TH - Thailandia 2
BB - Barbados 1
BQ - ???statistics.table.value.countryCode.BQ??? 1
BS - Bahamas 1
CG - Congo 1
CI - Costa d'Avorio 1
CU - Cuba 1
DM - Dominica 1
GD - Grenada 1
Totale 19.416
Città #
Singapore 983
Hong Kong 982
Moscow 858
San Jose 567
Ashburn 564
Dallas 563
Shanghai 425
Hefei 389
Lawrence 379
Princeton 379
Lauterbourg 334
Ho Chi Minh City 234
Beijing 214
Hanoi 128
São Paulo 126
Milan 82
Los Angeles 79
New York 77
Helsinki 75
Nuremberg 70
Dublin 58
Rio de Janeiro 53
Pune 49
Boardman 45
Santa Clara 39
The Dalles 37
Da Nang 36
Johannesburg 36
Munich 35
Haiphong 33
Belo Horizonte 29
Columbus 28
Mykolayiv 28
Warsaw 28
Washington 28
Guangzhou 27
Orem 27
Brasília 26
Seattle 25
Chennai 24
Biên Hòa 23
Salvador 23
Vienna 22
Atlanta 21
Guayaquil 21
Brooklyn 20
Curitiba 20
Denver 20
Tashkent 20
Baghdad 19
Buenos Aires 18
Montreal 18
Phoenix 18
Turku 18
Hangzhou 17
Nairobi 17
Tianjin 17
Campinas 16
Changsha 16
London 16
Mexico City 16
Porto Alegre 16
Shenzhen 16
Chicago 15
Goiânia 15
Houston 15
Frankfurt am Main 14
Jakarta 14
Poplar 14
Ribeirão Preto 14
Guarulhos 13
Hải Dương 13
Manchester 13
Tokyo 13
Council Bluffs 12
Dhaka 12
Santo André 12
Stockholm 12
Aracaju 11
Asunción 11
Boston 11
Contagem 11
Franca 11
Recife 11
Rome 11
São José dos Campos 11
Thái Bình 11
Lahore 10
Quito 10
Santiago 10
Toronto 10
Caxias do Sul 9
Manaus 9
Philadelphia 9
Presidente Prudente 9
San Francisco 9
Sorocaba 9
Brescia 8
Bắc Giang 8
Can Tho 8
Totale 9.045
Nome #
"African sickness" and the heart: the mysteries of endomyocardial fibrosis. 198
3D analysis of mitral annular reshape with third generation MitraClip XTr in functional and degenerative mitral regurgitation 152
ST-Segment-Elevation Myocardial Infarction During COVID-19 Pandemic: Insights From a Regional Public Service Healthcare Hub 119
Clinical profiling and outcomes of viral myocarditis manifesting with ventricular arrhythmias 115
Epicardial adipose tissue characteristics, obesity and clinical outcomes in COVID-19: A post-hoc analysis of a prospective cohort study 115
[Selective vasodilatation of the subepicardial coronary vasculature induced by carbochromen (author's transl)]. FT Vasodilatazione selettiva della vascolatura coronarica sottoepicardica indotta dal carbocromene. 100
The spectrum of covid-19-associated myocarditis: A patient-tailored multidisciplinary approach 97
[Microcirculation and remodelling]. FT Microcircolo e "remodelling". 94
A Critical Reappraisal of Differences in Cardiac Resynchronization Therapy Defibrillator Effectiveness Between Men and Women in the MADIT-CRT Trial 93
Carotid atherosclerosis, silent ischemic brain damage and brain atrophy: A systematic review and meta-analysis 88
123I-mIBG scintigraphy to predict risk for adverse cardiac outcomes in heart failure patients: design of two prospective multicenter onternational trials 87
[Metabolism of myocardial glycogen during ischemia and reperfusion]. FT Metabolismo del glicogeno miocardico durante ischemia e riperfusione. 86
[Dual model of coronary vasodilation response to adenosine]. FT Modello della doppia risposta vasodilatatrice coronarica all'adenosina. 85
Extent and characteristics of carotid plaques and brain parenchymal loss in asymptomatic patients with no indication for revascularization 84
Cardiac magnetic resonance predictors of left ventricular remodelling following acute ST elevation myocardial infarction: The VavirimS study 83
[Psychological and social aspects in women with syndrome X]. FT Aspetti psicologici e sociali nelle donne con sindrome X. 83
A change of scene: Paolo Camici, MD, FRCP, FESC. Interview by Emma Wilkinson. 82
A high-volume single center experience of no-reflow post-percutaneous coronary intervention 80
[Effect of contraction on the distribution of coronary flow]. FT Effetto della contrazione sulla distribuzione del flusso coronarico. 80
Pregression of brain white matter hyperintensities in asymptomatic patients with carotid atherosclerosis plaques and no indication for revascularization 80
[Progressive increase of the coronary flow above peak reactive hyperemia during prolonged intracoronary infusion of adenosine (author's transl)]. FT Aumento progressivo del flusso coronarico oltre i valori dell'iperemia reattiva durante infusione intracoronarica prolungata di adenosina. 79
[Metabolic characterization of the angina syndrome with F-18-deoxyglucose using positron tomography]. FT Caratterizzazione metabolica delle sindromi anginose con F-18-desossiglucosio mediante tomografia a positroni. 79
Myocardial hibernation vs repetitive stunning in patients. 78
[Myocardial imaging with 99mTC albumin microspheres for the simultaneous assessment of contraction and perfusion in man]. FT L'impiego della scintigrafia miocardica con microsfere di albumina marcate con 99mTecnezio nella contemporanea valutazione della contrattilita e della perfusione nell'uomo. 78
IMPACT OF THE MEDITERRANEAN DIET ON PATIENTS WITH A FIRST ACUTE MYOCARDIAL INFARCTION 78
[Indications for a model of coronary circulation derived from the study of transmural myocardial perfusion]. FT Indicazioni per un modello della circolazione coronarica derivate dallo studio della perfusione miocardica transmurale. 77
A new technique for multitracer macroscopic autoradiography. 77
Reappraisal of Ischemic Heart Disease 75
36. Dutka DP, Pitt M, Pagano D, Mongillo M, Gathercole D, Bonser RS, Camici P. 74
Clinical Presentation and Outcome in a Contemporary Cohort of Patients With Acute Myocarditis 74
Myocardial viability assessment during Impella support with 18-fluorodesoxyglucose PET imaging 72
Investigation of myocardial metabolism for the study of the pathophysiology of cardiac disease. 72
DOBUTAMINE STRESS - EFFECTS ON REGIONAL MYOCARDIAL BLOOD-FLOW AND WALL-MOTION 72
CORONARY HEMODYNAMICS AND MYOCARDIAL-METABOLISM IN PATIENTS WITH SYNDROME-X - RESPONSE TO PACING STRESS 71
Beneficial effect of nitrates on myocardial glucose utilization in unstable angina pectoris. 71
[Stunning, hibernation, and heart failure in patients with coronary disease: crucial role of impaired coronary flow reserve]. FT Stunning, hibernation ed insufficienza cardiaca nei pazienti con malattia coronarica: il ruolo centrale di una ridotta riserva coronarica. 71
Coronary vasodilator reserve in primary and secondary left ventricular hypertrophy - A study with positron emission tomography 70
Anti-anginal drugs: Systematic review and clinical implications 70
Myocardial revascularization for the treatment of post-ischemic heart failure 69
METABOLIC MARKERS OF STRESS-INDUCED MYOCARDIAL-ISCHEMIA 69
Anatomic versus Physiologic Assessment of Coronary Artery Disease: Role of CFR, FFR, and PET Imaging in Revascularization Decision-Making 69
Variation in neurosurgical management of traumatic brain injury: a survey in 68 centers participating in the CENTER-TBI study 69
Septal Late Gadolinium Enhancement and Arrhythmic Risk in Genetic and Acquired Non-Ischaemic Cardiomyopathies 69
[The distribution of the coronary flow with a perfusion pressure superior to the left ventricular systolic pressure]. FT La distribuzione del flusso coronarico a pressione di perfusione superiore alla pressione sistolica ventricolare sinistra. 68
Coronary Microvascular Resistance: methods for its quantification in human 68
Integrated Non-invasive Physiological Assessment of Coronary Circulatory Function and Impact on Cardiovascular Mortality in Patients with Stable Coronary Artery Disease 68
Coronary microvascular dysfunction 67
INFLUENCE OF SELECTIVE AUTONOMIC DECENTRALIZATION ON MYOCARDIAL DEOXYGLUCOSE UPTAKE INITIATED BY CARDIOCARDIAC REFLEXES 67
Transmural myocardial blood flow distribution in hypertrophic cardiomyopathy and effect of treatment 67
Pathophysiology of Takotsubo Syndrome 67
The viable myocardium 66
Prolonged metabolic recovery allows late identification of ischemia in the absence of electrocardiographic and perfusion changes in patients with exertional angina. 66
Incidence of stunned, hibernating and scarred myocardium in ischaemic cardiomyopathy 66
Uneven myocardial glucose utilization as determined by regional 14C-deoxyglucose uptake. 65
Low frequency spectral component of heart rate variability and myocardial beta-adrenoceptor density after acute myocardial infarction 65
Time-dependent response of coronary flow to prolonged adenosine infusion: doubling of peak reactive hyperaemic flow. 65
International standardization of diagnostic criteria for microvascular angina 65
Role of multimodality cardiac imaging in the management of patients with hypertrophic cardiomyopathy: an expert consensus of the European Association of Cardiovascular Imaging Endorsed by the Saudi Heart Assocation. 64
Different respiratory activities of mitochondria isolated from the subendocardium and subepicardium of the canine heart. 64
Relation between regional myocardial uptake of rubidium-82 and perfusion: absolute reduction of cation uptake in ischemia. 63
Positron emission tomography to assess the haemodynamics of the coronary circulation. 63
Hibernation and congestive heart failure 63
Cardiomyopathy in duchenne, becker, and sarcoglycanopathies: A role for coronary dysfunction? 62
Digital autoradiography: film and electronic multitracer techniques for heart imaging. 62
Myocardial beta adrenoceptors and left ventricular function in hypertrophic cardiomyopathy 62
Guidelines on the management of stable angina pectoris: executive summary: The Task Force on the Management of Stable Angina Pectoris of the European Society of Cardiology 62
Eosinophilic Myocarditis: Characteristics, Treatment, and Outcomes 62
RELATION BETWEEN MYOCARDIAL BLOOD-FLOW AND THE SEVERITY OF CORONARY-ARTERY STENOSIS 62
Correlation between hydroperoxide-induced chemiluminescence of the heart and its function. 61
Coronary recanalisation, myocardial viability, and ventricular remodelling after infarction 61
CMR First-Pass Perfusion for Suspected Inducible Myocardial Ischemia 61
Fulminant Versus Acute Nonfulminant Myocarditis in Patients With Left Ventricular Systolic Dysfunction 61
Uptake of [N-methyl-C-11]propionyl-L-carnitine (PLC) in human myocardium 60
Opposite transmural gradients of coronary resistance and extravascular pressure in the working dog's heart. 60
Long-Term Prognosis and Outcome Predictors in Takotsubo Syndrome: A Systematic Review and Meta-Regression Study 60
Prevalence, Burden and Echocardiographic Features of Moderate to Severe Tricuspid Regurgitation: Insights from a Tertiary Referral Center (vol 3, pg 123, 2019) 60
Coronary microvascular dysfunction and prognosis in hypertrophic cardiomyopathy 59
Myocardial metabolism in ischemic heart disease: basic principles and application to imaging by positron emission tomography. 59
Identification of High-Risk Patients after ST-Segment-Elevation Myocardial Infarction 59
Cardiac Sympathetic Imaging with MIBG in Heart Failure 58
Coronary microvascular dysfunction: An update 58
Hybrid cardiac PET/MR: the value of multiparametric assessment in cardiac sarcoidosis 58
Myocardial stunning is associated with impaired calcium uptake by sarcoplasmic reticulum 57
PATHOPHYSIOLOGICAL DILEMMA OF SYNDROME-X 57
Does positron emission tomography contribute to the management of clinical cardiac problems? 57
Immunocytochemical evidence for inducible nitric oxide synthase and cyclooxygenase-2 expression with nitrotyrosine formation in human hibernating myocardium 57
Resting myocardial blood flow in patients with hibernating myocardium quantified by positron emission tomography 57
Imaging of Vascular Inflammation with [11C]-PK11195 and PET/CT Angiography 57
NONINVASIVE IDENTIFICATION OF LIMITED CORONARY FLOW RESERVE IN HYPERTROPHIC CARDIOMYOPATHY 57
Syndrome X: background, clinical aspects, pathophysiology & treatment. 57
Myocardial viability in ischemic left ventricular dysfunction (Letter) 57
Calcified left ventricular endomyocardial fibrosis 57
Variability of the lumped constant for [F-18]2-deoxy-2-fluoroglucose and the experimental isolated rat heart model: Clinical perspectives for the measurement of myocardial tissue viability in humans 57
Takotsubo: One, no one and one hundred thousand diseases 57
AN ADDITIONAL MARKER FOR FAMILIAL HYPERTROPHIC CARDIOMYOPATHY 56
An accordion not to be played 56
Myocardial presynaptic and postsynaptic autonomic dysfunction in hypertonic cardiomyopathy 56
Coronary revascularization in the treatment of moderate and severe postischemic left ventricular dysfunction 56
Effects of Gender on Coronary Microvascular Dysfunction and Cardiac Outcomes 56
Advances in SPECT and PET for the management of heart failure 56
Totale 7.158
Categoria #
all - tutte 145.579
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 145.579


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20212 0 0 0 0 0 0 0 0 0 0 0 2
2021/2022149 0 0 2 76 19 8 6 3 9 5 5 16
2022/20231.931 859 387 124 6 7 224 63 113 115 8 11 14
2023/2024549 34 20 44 55 41 132 33 42 6 18 44 80
2024/20254.216 592 82 15 92 58 389 583 319 861 628 295 302
2025/202612.578 1.082 1.173 901 1.864 803 261 1.340 916 3.620 618 0 0
Totale 19.617